Skip to main content

Table 8 Treatment progress and changes in the serum carbohydrate antigen 72-4 (CA72-4) level among different stages

From: Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment

Stage

Baseline CA72-4 levels

Post CA72-4 levels

P*

Decreased

P†

Decreased > 20%

P†

All patients

2.99 (1.45, 8.64)

2.92 (1.54, 7.12)

0.801

272 (51.03)

0.594

209 (39.21)

0.592

0

2.12 (1.06, 5.07)

2.03 (1.29, 3.71)

0.951

16 (47.06)

 

14 (41.18)

 

I

2.03 (1.26, 4.56)

2.15 (1.33, 5.30)

0.420

48 (46.60)

 

37 (35.92)

 

II

2.84 (1.31, 7.62)

2.92 (1.50, 6.91)

0.566

80 (50.31)

 

58 (36.48)

 

III

3.67 (1.96, 12.12)

3.69 (1.64, 8.17)

0.564

128 (54.01)

 

100 (42.19)

 
  1. *P value for Wilcoxon test; †P value for chi-square test
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us